Potent amyloidogenicity and pathogenicity of Aβ 243

Nature Neuroscience

Volumn 14, Issue 8, 2011, Pages 1023-1032

  Saito, Takashi ^a   Suemoto, Takahiro ^a   Brouwers, Nathalie ^b,c   Sleegers, Kristel ^b,c   Funamoto, Satoru ^d   Mihira, Naomi ^a   Matsuba, Yukio ^a   Yamada, Kazuyuki ^a   Nilsson, Per ^a   Takano, Jiro ^a   Nishimura, Masaki ^e   Iwata, Nobuhisa ^a,f   Van Broeckhoven, Christine ^b,c   Ihara, Yasuo ^d   Saido, Takaomi C ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d DOSHISHA UNIVERSITY   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE FUNCTION; HOMOZYGOSITY; HUMAN; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; MUTATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ARGININE; CELL LINE, TUMOR; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; ISOLEUCINE; L-LACTATE DEHYDROGENASE; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; PRESENILIN-1;

EID: 79960819248     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.2858     Document Type: Article

References (50)

1. Blennow, K., de Leon, M.J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387-403 (2006). (Pubitemid 44108123)
2. Miravalle, L. et al. Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques. Biochemistry 44, 10810-10821 (2005). (Pubitemid 41153641)
3. Van Vickle, G.D. et al. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered γ-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry 46, 10317-10327 (2007).
4. Iizuka, T. et al. Amyloid β-protein ending at Thr43 is a minor component of some diffuse plaques in the Alzheimer's disease brain, but is not found in cerebrovascular amyloid. Brain Res. 702, 275-278 (1995). (Pubitemid 3011418)
5. Parvathy, S. et al. Correlation between Aßx-40-, Aßx-42-and Aßx-43-containing amyloid plaques and cognitive decline. Arch. Neurol. 58, 2025-2032 (2001).
6. Welander, H. et al. Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains. J. Neurochem. 110, 697-706 (2009).
7. Keller, L. et al. The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions. Eur. J. Hum. Genet. 18, 1202-1208 (2010).
8. Qi-Takahara, Y. et al. Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase. J. Neurosci. 25, 436-445 (2005). (Pubitemid 40105614)
9. Takami, M. et al. γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment. J. Neurosci. 29, 13042-13052 (2009).
10. Shimojo, M. et al. Enzymatic characteristics of I213T mutant Presenilin-1/γ-secretase in cell models and knock-in mouse brains: FAD-linked mutation impairs γ-site cleavage of APP-CTFβ. J. Biol. Chem. 283, 16488-16496 (2008).
11. Jarrett, J.T., Berger, E.P. & Lansbury, P.T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697 (1993). (Pubitemid 23162022)
12. Bitan, G. et al. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100, 330-335 (2003).
13. Nakaya, Y. et al. Random mutagenesis of presenilin-1 identifies novel mutants exclusively generating long amyloid β-peptides. J. Biol. Chem. 280, 19070-19077 (2005). (Pubitemid 41379613)
14. Godbolt, A.K. et al. A presenilin 1 R278I mutation presenting with language impairment. Neurology 63, 1702-1704 (2004). (Pubitemid 39507593)
15. Shen, J. et al. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997). (Pubitemid 27511773)
16. Wong, P.C. et al. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997). (Pubitemid 27220764)
17. Culvenor, J.G. et al. Characterization of presenilin complexes from mouse and human brain using blue native gel electrophoresis reveals high expression in embryonic brain and minimal change in complex mobility with pathogenic presenilin mutations. Eur. J. Biochem. 271, 375-385 (2003). (Pubitemid 38130465)
18. Evin, G. et al. Transition-state analogue γ-secretase inhibitors stabilize a 900 kDa presenilin/nicastrin complex. Biochemistry 44, 4332-4341 (2005). (Pubitemid 40403974)
19. Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (1996). (Pubitemid 26251602)
20. Lee, M.K. et al. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat. Med. 3, 756-760 (1997). (Pubitemid 27298719)
21. Kaneko, H. et al. Enhanced accumulation of phosphorylated α-synuclein and elevated β-amyloid 42/40 ratio caused by expression of the presenilin-1 ΔT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease. J. Neurosci. 27, 13092-13097 (2007). (Pubitemid 350225495)
22. Schroeter, E.H. et al. A presenilin dimer at the core of the γ-secretase enzyme: insight from parallel analysis of Notch1 and APP proteolysis. Proc. Natl. Acad. Sci. USA 100, 13075-13080 (2003). (Pubitemid 37340028)
23. Hama, E., Shirotani, K., Iwata, N. & Saido, T.C. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid β peptide clearance in primary neurons. J. Biol. Chem. 279, 30259-30264 (2004). (Pubitemid 38937952)
24. Kumar-Singh, S. et al. Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Hum. Mutat. 27, 686-695 (2006).
25. Wang, R., Wang, B., He, W. & Zheng, H. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J. Biol. Chem. 281, 15330-15336 (2006). (Pubitemid 43855123)
26. Maeda, J. et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 27, 10957-10968 (2007). (Pubitemid 47574168)
27. Saido, T.C. et al. Dominant and differential deposition of distinct β-amyloid peptide species, AßN3(pE), in senile plaques. Neuron 14, 457-466 (1995).
28. Schilling, S. et al. Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology. Nat. Med. 14, 1106-1111 (2008).
29. Zhang, C. et al. Presenilins are essential for regulating neurotransmitter release. Nature 460, 632-636 (2009).
30. Russo, C. et al. Presenilin-1 mutations in Alzheimer's disease. Nature 405, 531-532 (2000). (Pubitemid 30367716)
31. McGowan, E. et al. Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199 (2005). (Pubitemid 41019251)
32. Kim, J. et al. Aβ40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633 (2007). (Pubitemid 46143766)
33. Ono, K., Condron, M. & Teplow, D.B. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity. J. Biol. Chem. 285, 23186-23197 (2010).
34. Jan, A. et al. The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283, 28176-28189 (2008).
35. Huppert, S.S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970 (2000). (Pubitemid 30435055)
36. Ikeuchi, T. et al. Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Aβ1-40 and Aβ1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of "γ-secretase". J. Biol. Chem. 278, 7010-7018 (2003). (Pubitemid 36800696)
37. Serneels, L. et al. γ-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324, 639-642 (2009).
38. Bentahir, M. et al. Presenilin clinical mutations can affect γ-secretase activity by different mechanisms. J. Neurochem. 96, 732-742 (2006).
39. Deng, Y. et al. Deletion of presenilin 1 hydrophilic loop sequence leads to imparired γ-secretase activity and exacerbated amyloid pathology. J. Neurosci. 26, 3845-3854 (2006).
40. Hara, H. et al. Development of a safe oral Aβ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J. Alzheimers Dis. 6, 483-488 (2004). (Pubitemid 40916690)
41. Mouri, A. et al. Oral vaccination with a viral vector containing Aβ cDNA attenuates age-related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J. 21, 2135-2148 (2007). (Pubitemid 47026449)
42. Kimura, N. et al. Senile plaques in an aged Western Lowland Gorilla. Exp. Anim. 50, 77-81 (2001). (Pubitemid 33620372)
43. Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292 (1997). (Pubitemid 27518514)
44. Huang, S.-M. et al. Neprilysin-sensitive synapse-associated amyloid-β peptide oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. 281, 17941-17951 (2006). (Pubitemid 44035593)
45. Kopan, R., Schroeter, E.H., Weintraub, H. & Nye, J.S. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl. Acad. Sci. USA 93, 1683-1688 (1996). (Pubitemid 26075185)
46. Iwata, N. et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain. J. Neurosci. 24, 991-998 (2004). (Pubitemid 38146610)
47. Iwatsubo, T. et al. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45-53 (1994).
48. Enya, M. et al. Appearance of sodium dodecylsulfate-stable amyloid β-protein (Aβ) dimer in the cortex during aging. Am. J. Pathol. 154, 271-279 (1999). (Pubitemid 29031634)
49. Ryan, D.A., Narrow, W.C., Federoff, H.J. & Bowers, W.J. An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies. J. Neurosci. Res. 190, 171-179 (2010).
50. Arango, D. et al. Systemic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid β precursor protein and presenilin gene in Colombia. Am. J. Med. Genet. 103, 138-143 (2001).